On 2025-05-06, Keros Therapeutics, Inc. (KROS) announced earnings per share of $3.62 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.01.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-1.13 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-06 | 2025-03-31 | $-0.01 | $3.62 |
| 2025-02-26 | 2024-12-31 | $-0.93 | $-1.14 |
| 2024-11-06 | 2024-09-30 | $-1.26 | $-1.41 |
| 2024-08-07 | 2024-06-30 | $-1.23 | $-1.25 |
| 2024-05-08 | 2024-03-31 | $-1.31 | $-1.21 |
| 2024-02-28 | 2023-12-31 | $-1.38 | $-1.34 |
| 2023-11-06 | 2023-09-30 | $-1.34 | $-1.33 |
| 2023-08-07 | 2023-06-30 | $-1.34 | $-1.27 |
| 2023-05-04 | 2023-03-31 | $-1.13 | $-1.26 |
| 2023-03-03 | 2022-12-31 | $-1.12 | $-1.09 |
| 2022-11-03 | 2022-09-30 | $-1.26 | $-0.92 |
| 2022-08-04 | 2022-06-30 | $-1.07 | $-1.13 |
| 2022-05-05 | 2022-03-31 | $-0.86 | $-1.01 |
| 2022-03-09 | 2021-12-31 | $-0.94 | $-0.30 |
| 2021-11-04 | 2021-09-30 | $-0.72 | $-0.87 |
| 2021-08-05 | 2021-06-30 | $-0.66 | $-0.67 |
| 2021-05-06 | 2021-03-31 | $-0.58 | $-0.68 |
| 2021-03-25 | 2020-12-31 | $-0.57 | $-0.49 |
| 2020-11-10 | 2020-09-30 | $-0.58 | $-0.60 |
| 2020-08-13 | 2020-06-30 | $-0.51 | $-0.62 |
| 2020-05-22 | 2020-03-31 | $-0.37 | $-5.11 |